Patients give biologics a good rap on social media
And positive comments just outweigh negatives for conventional DMARDs too, analysis shows.
Tag: Musculoskeletal – Rheumatic disorders
Immune system ‘back to normal’ after kids’ Kawasaki-like illness
The disease associated with COVID-19 is mostly self-limiting, researchers say.
Nerve stimulation to be trialled for refractory RA
Pilot trial of a device the size of a coffee bean shows it is well tolerated.
Is hydroxychloroquine safe in RA?
Long-term use is linked to raised risk of cardiac deaths, data show.
Which factors affect giant cell arteritis outcomes?
Researchers set out to investigate findings from disparate studies in a single cohort of patients.
Belimumab paediatric trial results ‘consistent with adult studies’
Longer follow-up needed to see renal outcomes, commentator says.
Polymyalgia rheumatica doesn’t raise risk of mortality: study
Patients'Â slightly higher risk of vascular death might be balanced by a reduced risk of dying from cancer, researchers say.
Lupus carries high risk of all-cause mortality in the young
Study also shows a survival benefit of low-dose hydroxychloroquine.
Autoimmune diseases linked to raised risk of cervical dysplasia
Until now there has been a dearth of data on the HPV burden in Australian immunocompromised women, researchers say.
COVID-19 more severe with certain rheumatic diseases: study
Patients on biologics, but not conventional DMARDs, are also at increased risk, researchers say.
